Trial Profile
Phase III, Multicenter, Ramdomised, Open-Label, Study to Evaluate the Safety and Efficacy of Combination Therapy With XELOX Vs. Oxaliplatin and 5-FU CI as First Line Treatment in Advanced or Metastatic Colorectal Cancer.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil (Primary) ; Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 04 Jun 2009 New trial record.